Patents by Inventor Uri DANON

Uri DANON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
    Publication number: 20220023377
    Abstract: The present invention provides methods for treating or ameliorating primary progressive multiple sclerosis (PPMS) or secondary progressive multiple sclerosis (SPMS) and related symptoms by administering or implanting a depot formulation comprising glatiramer salts, such as glatiramer acetate (GA).
    Type: Application
    Filed: October 6, 2021
    Publication date: January 27, 2022
    Applicant: MAPI PHARMA LTD.
    Inventors: Uri DANON, Nadav BLEICH KIMELMAN, Laura POPPER, Ehud MAROM
  • Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
    Patent number: 11167003
    Abstract: The present invention provides methods for treating or ameliorating primary progressive multiple sclerosis (PPMS) or secondary progressive multiple sclerosis (SPMS) and related symptoms by administering or implanting a depot formulation comprising glatiramer salts, such as glatiramer acetate (GA).
    Type: Grant
    Filed: March 25, 2018
    Date of Patent: November 9, 2021
    Assignee: MAPI PHARMA LTD.
    Inventors: Uri Danon, Nadav Bleich Kimelman, Laura Popper, Ehud Marom
  • DEPOT SYSTEMS COMPRISING GLATIRAMER ACETATE
    Publication number: 20210283209
    Abstract: The present invention provides compositions and methods of use thereof for treating or ameliorating multiple sclerosis (MS) by administering a depot formulation comprising 40 mg glatiramer acetate intramuscularly to the MS patient.
    Type: Application
    Filed: August 9, 2017
    Publication date: September 16, 2021
    Applicant: MAPI PHARMA LTD.
    Inventors: Ehud MAROM, Nadav BLEICH KIMELMAN, Uri DANON, Shai RUBNOV
  • GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
    Publication number: 20200376069
    Abstract: The present invention provides methods for treating or ameliorating primary progressive multiple sclerosis (PPMS) or secondary progressive multiple sclerosis (SPMS) and related symptoms by administering or implanting a depot formulation comprising glatiramer salts, such as glatiramer acetate (GA).
    Type: Application
    Filed: March 25, 2018
    Publication date: December 3, 2020
    Applicant: MAPI PHARMA LTD.
    Inventors: Uri DANON, Nadav BLEICH KIMELMAN, Laura POPPER, Ehud MAROM